KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $137,000 | 0.0% | 1,083 | 0.0% | 0.00% | – |
Q1 2022 | $137,000 | -99.9% | 1,083 | -99.9% | 0.00% | -100.0% |
Q4 2021 | $120,205,000 | +7.1% | 917,602 | +0.0% | 0.22% | +4.7% |
Q3 2021 | $112,212,000 | +5.6% | 917,291 | -1.6% | 0.21% | +8.1% |
Q2 2021 | $106,236,000 | -10.8% | 931,984 | -5.9% | 0.20% | -14.3% |
Q1 2021 | $119,064,000 | +122.8% | 990,306 | +88.3% | 0.23% | +111.9% |
Q4 2020 | $53,436,000 | +103.2% | 525,993 | +54.6% | 0.11% | +75.8% |
Q3 2020 | $26,298,000 | -33.0% | 340,121 | -3.4% | 0.06% | -36.1% |
Q2 2020 | $39,228,000 | +83.8% | 351,946 | +18.7% | 0.10% | +54.0% |
Q1 2020 | $21,342,000 | +2134100.0% | 296,411 | +14820450.0% | 0.06% | – |
Q4 2019 | $1,000 | – | 2 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |